PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Independence Blue CrossCommercial · Administrative · Pharmacy · PA · Ophthalmology, PharmacyLow impact

08.01.44c, Voretigene Neparvovec-rzyl (Luxturna®)

Effective date
Not stated in the notice
Identified
Jun 19, 2026

Summary

This is a reissue with no substantive changes to Independence Blue Cross Commercial Medical Policy 08.01.44c for voretigene neparvovec-rzyl (Luxturna). The policy maintains existing coverage criteria for RPE65 mutation-associated retinal dystrophy treatment and continues to use HCPCS code J3398. No billing workflow changes are required.

Get alerts when payers change rules like this one

We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.

Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.

What to do

Action · 4 steps
01No action required.
02This is a routine annual reissue with no changes to coverage criteria, billing codes, documentation requirements, or medical necessity guidelines.
03The policy 08.01.44c remains unchanged since its original effective date of 01/01/2019.
04Billing staff should continue processing Luxturna claims using existing procedures and documentation requirements.

Codes mentioned

J3398

Original notice

08.01.44c, Voretigene Neparvovec-rzyl (Luxturna®)
medpolicy.ibx.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account